Cell-Type-Specific Activation and Repression of PU.1 by a Complex of Discrete, Functionally Specialized cis-Regulatory Elements
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The transcription factor PU.1 is critical for multiple hematopoietic lineages, but different leukocyte types require strictly distinct patterns of PU.1 regulation. PU.1 is required early for T-cell lineage development but then must be repressed by a stage-specific mechanism correlated with commitment. Other lineages require steady, low expression or upregulation. Until now, only the promoter plus a distal upstream regulatory element (URE) could be invoked to explain nearly all Sfpi1 (PU.1) activation and repression, including bifunctional effects of Runx1. However, the URE is dispensable for most Sfpi1 downregulation in early T cells, and we show that it retains enhancer activity in immature T-lineage cells even where endogenous Sfpi1 is repressed. We now present evidence for another complex of conserved noncoding elements that mediate discrete, cell-type-specific regulatory features of Sfpi1, including a myeloid cell-specific activating element and a separate, pro-T-cell-specific silencer element. These elements yield opposite, cell-type-specific responses to Runx1. T-cell-specific repression requires Runx1 acting through multiple nonconsensus sites in the silencer core. These newly characterized sites recruit Runx1 binding in early T cells in vivo and define a functionally specific scaffold for dose-dependent, Runx-mediated repression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The best current candidates for this silencing activity include GATA-3 (104, 105), TCF-1 or LEF-1 (37), and especially Runx1 (80, 150–152), probably working in a dose-dependent combination, although the mechanism through which they finally achieve the ability to repress PU.1 has not yet been reported.”
From Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development (2019) · cites this paper as [152]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PU.1 has been previously linked to proliferation in macrophages. Bone-marrow derived Macrophages over-expressing PU.1 increased GM-CSF and M-CSF dependent proliferation and cell number, the opposite was seen in cells transfected with an anti-sense PU.19.”
From Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease (2021) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“1 is essential for the development of myeloid and lymphoid lineages (22, 30), but inappropriately controlled expression can cause severe developmental defects and/or malignancy.”
BackgroundTargeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 1×
“1 is essential for the development of myeloid and lymphoid lineages (22, 30), but inappropriately controlled expression can cause severe developmental defects and/or malignancy.”
BackgroundmicroRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells
Vigorito, E., Perks, K. L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, P. P., Miska, E. A., Rodriguez, A., Bradley, A., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.009 · Cited by 763 · cited 1×
“1 expression, such as antisense transcription (11) and miRNA suppression (36), have explained only modest differences in the level, inadequate to account for the 2 to 3 orders of magnitude of repression that Sfpi1 undergoes during T-lineage commitment.”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730 · cited 3×
“1 expression is silenced during the transition to the DN3 stage of T-cell development, as the cells undergo lineage commitment (3, 33, 35).”
BackgroundAcute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506 · cited 2×
“1 expression within hematopoietic cells nor fully blocked T-cell silencing (28, 29).”
BackgroundLoss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3280 · Cited by 462 · cited 2×
“In T-lineage cells, deletion of Runx1 produces a developmental block at the DN2 stage (13, 18), and the surviving cells have higher PU.”
BackgroundLaiosa, C. V., Stadtfeld, M., Xie, H., de Andres-Aguayo, L., & Graf, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.011 · Cited by 351 · cited 1×
“2C2, can also cause the cells to gain myeloid characteristics (2, 10, 19), linking the silencing of PU.”
BackgroundDynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
Nutt, S. L., Metcalf, D., D'Amico, A., Polli, M., & Wu, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041535 · Cited by 325 · cited 1×
“1 expression is silenced in erythroid cells but elevated in macrophages, continues at moderately high levels in neutrophils and most types of dendritic cells, and is fixed at lower levels in committed B cells (4, 24).”
BackgroundTaghon, T., Yui, M. A., Pant, R., Diamond, R. A., & Rothenberg, E. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.012 · Cited by 312 · cited 1×
“Therefore, the binding of Runx proteins to CE4A was confirmed by competition in gel shifts against a validated Runx-dependent silencer sequence, the Cd4 silencer (32) (Fig.”
BackgroundSelf-citationArinobu, Y., Mizuno, S.-I., Chong, Y., Shigematsu, H., Iino, T., Iwasaki, H., Graf, T., Mayfield, R., Chan, S., Kastner, P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.004 · Cited by 309
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259 · cited 3×
“Second, a Runx input into the URE was proposed to mediate silencing as well as activation (17).”
BackgroundInfluentialAnderson, M. K., Hernandez-Hoyos, G., Diamond, R. A., & Rothenberg, E. V. (1999) · Development · doi:10.1242/dev.126.14.3131 · Cited by 258
Self-citationRosenbauer, F., Owens, B. M., Yu, L., Tumang, J. R., Steidl, U., Kutok, J. L., Clayton, L. K., Wagner, K., Scheller, M., Iwasaki, H., et al. (2006) · Nature Genetics · doi:10.1038/ng1679 · Cited by 237 · cited 3×
“1 expression within hematopoietic cells nor fully blocked T-cell silencing (28, 29).”
Background(1995) · PubMed · Cited by 206
Spooner, C. J., Cheng, J. X., Pujadas, E., Laslo, P., & Singh, H. (2009) · Immunity · doi:10.1016/j.immuni.2009.07.011 · Cited by 188 · cited 1×
“1 and may thus contribute to autoregulation as well (26, 31).”
BackgroundAnderson, M. K., Weiss, A. H., Hernandez-Hoyos, G., Dionne, C. J., & Rothenberg, E. V. (2002) · Immunity · doi:10.1016/s1074-7613(02)00277-7 · Cited by 182 · cited 1×
“2C2, can also cause the cells to gain myeloid characteristics (2, 10, 19), linking the silencing of PU.”
BackgroundSelf-citationEbralidze, A. K., Guibal, F. C., Steidl, U., Zhang, P., Lee, S., Bartholdy, B., Jorda, M. A., Petkova, V., Rosenbauer, F., Huang, G., et al. (2008) · Genes & Development · doi:10.1101/gad.1654808 · Cited by 176 · cited 1×
“1 expression, such as antisense transcription (11) and miRNA suppression (36), have explained only modest differences in the level, inadequate to account for the 2 to 3 orders of magnitude of repression that Sfpi1 undergoes during T-lineage commitment.”
BackgroundPotential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element
Okuno, Y., Huang, G., Rosenbauer, F., Evans, E. K., Radomska, H. S., Iwasaki, H., Akashi, K., Moreau-Gachelin, F., Li, Y., Zhang, P., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2832-2845.2005 · Cited by 174
Deletion of β-catenin impairs T cell development
Xu, Y., Banerjee, D., Huelsken, J., Birchmeier, W., & Sen, J. M. (2003) · Nature Immunology · doi:10.1038/ni1008 · Cited by 168
Papathanasiou, P., Perkins, A. C., Cobb, B. S., Ferrini, R., Sridharan, R., Hoyne, G. F., Nelms, K. A., Smale, S. T., & Goodnow, C. C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00168-7 · Cited by 167 · cited 3×
“7A and D), might promote silencing, we further transfected the cells with a “dominant negative” mutant form of Ikaros called Plastic (27).”
BackgroundInfluentialLorsbach, R. B., Moore, J., Ang, S. O., Sun, W., Lenny, N., & Downing, J. R. (2004) · Blood · doi:10.1182/blood-2003-07-2439 · Cited by 130
Okada, H., Watanabe, T., Niki, M., Takano, H., Chiba, N., Yanai, N., Tani, K., Hibino, H., Asano, S., Mucenski, M. L., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202151 · Cited by 122 · cited 1×
“1 expression in HSCs depends on Runx1, which unfolds the chromatin structure of the Sfpi1 gene and primes it for expression (16, 25).”
BackgroundHoogenkamp, M., Lichtinger, M., Krysinska, H., Lancrin, C., Clarke, D., Williamson, A., Mazzarella, L., Ingram, R., Jorgensen, H., Fisher, A., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191890 · Cited by 121
C/EBPα binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment
Yeamans, C., Wang, D., Paz-Priel, I., Torbett, B. E., Tenen, D. G., & Friedman, A. D. (2007) · Blood · doi:10.1182/blood-2007-03-080291 · Cited by 118 · cited 3×
“In myeloid cells, the URE binds C/EBP (6, 38) and PU.”
BackgroundGraded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate
Chou, S. T., Khandros, E., Bailey, L. C., Nichols, K. E., Vakoc, C. R., Yao, Y., Huang, Z., Crispino, J. D., Hardison, R. C., Blobel, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-207944 · Cited by 110
Regulation of the PU.1 gene by distal elements
Li, Y., Okuno, Y., Zhang, P., Radomska, H. S., Chen, H.-M., Iwasaki, H., Akashi, K., Klemsz, M. J., McKercher, S. R., Maki, R. A., et al. (2001) · Blood · doi:10.1182/blood.v98.10.2958 · Cited by 110
Molecular Dissection of Prethymic Progenitor Entry into the T Lymphocyte Developmental Pathway
Tydell, C. C., David-Fung, E.-S., Moore, J. E., Rowen, L., Taghon, T., & Rothenberg, E. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.421 · Cited by 99
Self-citationCai, D. H., Wang, D., Keefer, J., Yeamans, C., Hensley, K., & Friedman, A. D. (2008) · Oncogene · doi:10.1038/sj.onc.1210940 · Cited by 96 · cited 3×
“In myeloid cells, the URE binds C/EBP (6, 38) and PU.”
BackgroundTelfer, J. C., Hedblom, E. E., Anderson, M. K., Laurent, M. N., & Rothenberg, E. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4359 · Cited by 84 · cited 1×
“First, we used cotransfections of a Runx1 dominant negative expression construct (d190) (34) together with the reporters to compete against endogenous Runx1 (Fig.”
MethodSelf-citationHoogenkamp, M., Krysinska, H., Ingram, R., Huang, G., Barlow, R., Clarke, D., Ebralidze, A., Zhang, P., Tagoh, H., Cockerill, P. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00905-07 · Cited by 63 · cited 1×
“The disparity between strong Runx1 binding at CE4A and weaker signals at CE8 in the T cells was unexpected in view of the established activity of Runx at CE8 and the open chromatin at CE8 in T and B cells alike (15), but this was highly reproducible.”
BackgroundCooperating pre–T-cell receptor and TCF-1–dependent signals ensure thymocyte survival
Goux, D., Coudert, J. D., Maurice, D., Scarpellino, L., Jeannet, G., Piccolo, S., Weston, K., Huelsken, J., & Held, W. (2005) · Blood · doi:10.1182/blood-2005-01-0337 · Cited by 62 · cited 1×
“1 repression at stages of development when T cells are known to require canonical Wnt signaling (12, 37).”
BackgroundOctamer Binding Factors and Their Coactivator Can Activate the Murine PU.1 (spi-1) Promoter
Chen, H.-M., Zhang, P., Radomska, H. S., Hetherington, C. J., Zhang, D.-E., & Tenen, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15743 · Cited by 59 · cited 1×
“1 can bind its own promoter with Sp1 to regulate itself in myeloid cells (8).”
BackgroundSubversion of T lineage commitment by PU.1 in a clonal cell line system
Dionne, C. J., Tse, K. Y., Weiss, A. H., Franco, C. B., Wiest, D. L., Anderson, M. K., & Rothenberg, E. V. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.01.027 · Cited by 54 · cited 1×
“2C2, can also cause the cells to gain myeloid characteristics (2, 10, 19), linking the silencing of PU.”
BackgroundSelf-citationDNA Methylation and Chromatin Structure Regulate PU.1 Expression
Amaravadi, L., & Klemsz, M. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314737 · Cited by 44 · cited 2×
“1-expressing and -nonexpressing cell types (1) (Fig.”
BackgroundHegde, S., Ni, S., He, S., Yoon, D., Feng, G. S., Watowich, S. S., Paulson, R. F., & Hankey, P. A. (2009) · Oncogene · doi:10.1038/onc.2009.202 · Cited by 35 · cited 1×
“4B and C), although it contains one reported Stat3 site implicated in Sfpi1 induction by cytokines (14).”
BackgroundKawazu, M., Yamamoto, G., Yoshimi, M., Yamamoto, K. Z., Asai, T., Ichikawa, M., Seo, S., Nakagawa, M. M., Chiba, S., Kurokawa, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5335 · Cited by 29 · cited 1×
“In T-lineage cells, deletion of Runx1 produces a developmental block at the DN2 stage (13, 18), and the surviving cells have higher PU.”
BackgroundAnalysis of DNase I Hypersensitive Site of the ELP Gene
Ninomiya, Y., Kotomura, N., & Niwa, O. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0795 · Cited by 3 · cited 1×
“hypersensitivity (HS) assays were carried out as described previously (23) with”
Method
Cited by
Developmental gene networks: a triathlon on the course to T cell identity
Yui, M. A., & Rothenberg, E. V. (2014) · Nature Reviews Immunology · doi:10.1038/nri3702 · Cited by 342
Self-citationZhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J., & Rothenberg, E. V. (2012) · Cell · doi:10.1016/j.cell.2012.01.056 · Cited by 337
“H3Ac disappeared from the promoter while H3K4me2 marks in the upstream cis-regulatory elements of the gene (Rosenbauer et al., 2006; Zarnegar et al., 2010) narrowed as transcription declined (Fig.”
Self-citationPositive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation
Kueh, H. Y., Champhekar, A., Nutt, S. L., Elowitz, M. B., & Rothenberg, E. V. (2013) · Science · doi:10.1126/science.1240831 · Cited by 273
“1 transcription during lymphoid and myeloid development [7, 10-14].”
Self-citationHow transcription factors drive choice of the T cell fate
Hosokawa, H., & Rothenberg, E. V. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00426-6 · Cited by 247
Self-citationTranscriptional Control of Early T and B Cell Developmental Choices
Rothenberg, E. V. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100024 · Cited by 215
Self-citation
Metadata
- Authors
- Zarnegar, M. A., Chen, J., & Rothenberg, E. V.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Rothenberg, Ellen V.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2010-10-01
- Volume
- 30
- Issue
- 20
- Pages
- 4922-4939
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2950536
- OpenAlex
- W2016316813
- Cited by
- 52
- References
- 38
- Citations by year
- 2025: 1 · 2024: 5 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Cancer Institute (R01CA090233)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK073658)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PU.1, RUNX1, cis-regulatory elements, enhancers, silencers, myeloid cells, transcriptional repression, transcriptional activation, hematopoietic lineage specification, cell type-specific gene regulation
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Base Sequence, Binding Sites, Cell Differentiation, Cell Line, Deoxyribonucleases, DNA, Enhancer Elements, Genetic, Genetic Complementation Test, Models, Biological, Molecular Sequence Data, Proto-Oncogene Proteins, Sequence Homology, Nucleic Acid, T-Lymphocytes, Trans-Activators, Conserved Sequence, Regulatory Elements, Transcriptional, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.